WASHINGTON, June 14, 2017 (GLOBE NEWSWIRE) -- Winning Strategies Washington is pleased to announce that Bobby Clark, a recognized leader in health policy, has joined the firm as Of Counsel.
Bobby most recently served as a Counselor to former Secretary of Health and Human Services Sylvia M. Burwell. In this capacity, he advised Secretary Burwell on policy matters related to public health and science. Bobby worked closely with the Department’s key public health and scientific agencies, including the Food and Drug Administration and the National Institutes of Health and as a policy leader for the Department’s efforts on President Obama’s Precision Medicine Initiative and the Cancer Moonshot Initiative.
Bobby previously served as a health policy advisor in the U.S. House of Representatives from 2003-2010 as a senior staff member of the House Energy and Commerce Committee, Subcommittee on Health and for Representative Frank Pallone, Jr. of New Jersey. Mr. Pallone is currently the Ranking Member of the full Energy and Commerce Committee. During Bobby’s time on Capitol Hill, he contributed to a number of legislative achievements, most notably the Affordable Care Act.
In serving as Of Counsel to the firm, Bobby will be focused on adding new health care clients and expanding service offerings, including detailed policy analysis of health care issues.
“Especially now, when clients have to navigate an immensely complicated health care policy and political landscape, Bobby is an incredible addition to our team. Bobby is also a longstanding friend and colleague, and we are thrilled to bring him back to his Jersey roots,” said Donna Mullins, Managing Partner of the firm.
“This is sort of a homecoming for me. New Jersey is home to so many organizations that are leading the way and innovating in health care. I can’t wait to roll up my sleeves and get to work helping guide clients’ legislative, regulatory and policy objectives,” added Bobby.
Prior to joining HHS, Bobby worked at PwC's Health Research Institute, where he led the Institute’s analysis of regulatory and policy initiatives impacting the pharmaceutical and life sciences industries. While at PwC, Bobby also advised leading healthcare companies on shifting trends in the US health care marketplace.